Blog

Ciara C. O’Sullivan of Mayo Clinic, leads the Alliance A011801 trial – Alliance for Clinical Trials in Oncology

Photo from Alliance for Clinical Trials in Oncology/LinkedIn

May 17, 2024, 13:16

Ciara C. O’Sullivan of Mayo Clinic, leads the Alliance A011801 trial – Alliance for Clinical Trials in Oncology

Alliance for Clinical Trials in Oncology shared on LinkedIn:

“For Trial Tuesday, Ciara C. O’Sullivan, MB, BCh, of Mayo Clinic, leads the Alliance A011801 (CompassHER2 RD) trial to see how targeted therapy linked to a chemotherapy drug works to prevent breast cancer from returning in patients with high-risk HER2+ breast cancer. To learn more about the CompassHER2 RD trial.”

Further Reading.
Source: Alliance for Clinical Trials in Oncology/LinkedIn

Alliance A011801 Alliance for Clinical Trials in Oncology cancer chemotherapy Ciara C. O'Sullivan CompassHER2 RD trial HER2+ breast cancer Mayo Clinic OncoDaily Oncology

Karen Knudsen: Better Together - Partnering to Accelerate Progress against Cancer

Sharon Osbourne and Colon Cancer: How She Went Against, How She Survived, and More

Marcia Cross and Anal Cancer: How She Went Against, How She Survived, and More

Pancreatic Cancer: Symptoms, Causes, Types, Diagnosis & Treatment

Former Disney CEO Bob Chapek Appointed Senior Adviser at SCAN Group

Special Coverage